Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Glucose-regulated insulin release from acid-disintegrable microgels covalently immobilized with glucose oxidase and catalase
Study Methodology Inclusion criteria included: BMI over 25 Age between 45 to 70 years No supplement consumption in the past three months No weight loss diet in the past three months No participation in other intervention programs Willingness to lose weight No history of heart, liver, kidney disease, diabetes, hypothyroidism, rheumatoid arthritis, or surgery After signing the informed consent form, participants were randomly assigned to an intervention group (21 individuals) and a control group (22 individuals)
The gastrointestinal tail Nausea, vomiting, diarrhea, and constipation account for the majority of adverse events and the majority of discontinuations within the first year of GLP-1 receptor agonist therapy
2003 Nov;57(3-4):14555
US$ 27.47
US$ 23.65
US$ 25.73
US$ 28.37
US$ 20.43
